Carregant...
Cetuximab could be more effective without prior bevacizumab treatment in metastatic colorectal cancer patients
Yasuyoshi Sato, Satoshi Matsusaka, Mitsukuni Suenaga, Eiji Shinozaki, Nobuyuki Mizunuma Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan Background: Cetuximab and bevacizumab reportedly improve the survival of patients with metastatic...
Guardat en:
Autors principals: | , , , , |
---|---|
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
Dove Medical Press
2015-11-01
|
Col·lecció: | OncoTargets and Therapy |
Accés en línia: | https://www.dovepress.com/cetuximab-could-be-more-effective-without-prior-bevacizumab-treatment--peer-reviewed-article-OTT |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|